NIKKEI 225
38,783.27 -116.75 (-0.30%) HANG SENG
18,888.92 +61.57 (+0.33%) CRUDE OIL
78.87 +1.15 (+1.48%) GOLD FUTURES
2,354.00 +19.50 (+0.84%) DOW
39,069.59 +4.29 (+0.01%) Bitcoin GBP
53,503.84 -573.40 (-1.06%)
Jazz Pharmaceuticals plc (J7Z.F)
| Previous close | 97.46 |
| Open | 96.98 |
| Bid | 97.36 x 1700 |
| Ask | 98.80 x 1700 |
| Day's range | 96.98 - 97.18 |
| 52-week range | 95.34 - 134.35 |
| Volume | |
| Avg. volume | 25 |
| Market cap | 6.166B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 21.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a strategic collaboration with Life Science Cares to drive social impact through employee volunteerism in the United States. This partnership reinforces Jazz's commitment to supporting the communities in which employees work and live. Life Science Cares is a collective effort to activate the financial and human capital of the life sciences industry across several regions in the U.S. – and partner with nonprofits – to disrupt the cycle of po
- PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the BofA Securities 2024 Global Health Care Conference on Wednesday, May 15, 2024, in Las Vegas. The fireside chat will be held at 10:00 a.m. PT / 1:00 p.m. ET / 6:00 p.m. IST.
- PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2024 and affirmed guidance for 2024.
